Blueprint Medicines Corp
NASDAQ:BPMC

Watchlist Manager
Blueprint Medicines Corp Logo
Blueprint Medicines Corp
NASDAQ:BPMC
Watchlist
Price: 129.46 USD 0.14%
Market Cap: 8.4B USD

Intrinsic Value

The intrinsic value of one BPMC stock under the Base Case scenario is 123.21 USD. Compared to the current market price of 129.46 USD, Blueprint Medicines Corp is Overvalued by 5%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

BPMC Intrinsic Value
123.21 USD
Overvaluation 5%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
Blueprint Medicines Corp

What is Valuation History?
Ask AI Assistant
What other research platforms think about BPMC?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is BPMC valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for Blueprint Medicines Corp.

Explain Valuation
Compare BPMC to

Fundamental Analysis

Company Overview
Loading...
Business Segments
Loading...
Economic Moat
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about BPMC?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Blueprint Medicines Corp

Current Assets 702.1m
Cash & Short-Term Investments 576.2m
Receivables 79.8m
Other Current Assets 46m
Non-Current Assets 493.5m
Long-Term Investments 323.5m
PP&E 97.7m
Other Non-Current Assets 72.3m
Current Liabilities 250.6m
Accounts Payable 800k
Accrued Liabilities 135.8m
Other Current Liabilities 114m
Non-Current Liabilities 602.9m
Long-Term Debt 343.9m
Other Non-Current Liabilities 258.9m
Efficiency

Free Cash Flow Analysis
Blueprint Medicines Corp

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Blueprint Medicines Corp

Revenue
562.1m USD
Cost of Revenue
-19.8m USD
Gross Profit
542.3m USD
Operating Expenses
-716.7m USD
Operating Income
-174.3m USD
Other Expenses
18.6m USD
Net Income
-155.7m USD
Fundamental Scores

BPMC Profitability Score
Profitability Due Diligence

Blueprint Medicines Corp's profitability score is 29/100. The higher the profitability score, the more profitable the company is.

ROIC is Increasing
Exceptional Gross Margin
ROE is Increasing
Strong 3Y Average Gross Margin
29/100
Profitability
Score

Blueprint Medicines Corp's profitability score is 29/100. The higher the profitability score, the more profitable the company is.

BPMC Solvency Score
Solvency Due Diligence

Blueprint Medicines Corp's solvency score is 40/100. The higher the solvency score, the more solvent the company is.

Short-Term Solvency
Negative Net Debt
Long-Term Solvency
Average D/E
40/100
Solvency
Score

Blueprint Medicines Corp's solvency score is 40/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

BPMC Price Targets Summary
Blueprint Medicines Corp

There are no price targets for BPMC.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates

Dividends

Blueprint Medicines Corp
does not pay dividends
Shareholder Yield

Current shareholder yield for BPMC is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y

Ownership

BPMC Insider Trading
Buy and sell transactions by insiders

BPMC News

Other Videos
What is the Intrinsic Value of one BPMC stock?

The intrinsic value of one BPMC stock under the Base Case scenario is 123.21 USD.

Is BPMC stock undervalued or overvalued?

Compared to the current market price of 129.46 USD, Blueprint Medicines Corp is Overvalued by 5%.

Back to Top